|

Multiple Sclerosis Clinical Trials in Michigan

18 recruiting studies across 10 cities

All Trials in Michigan

Phase
Trial Phase Location
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—Ann Arbor
A Study of AZD0120 in Autoimmune DiseasesPhase 1Ann Arbor
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersPhase 1Ann Arbor
Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) PatientsN/AAnn Arbor
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain PhenotypePhase 2Ann Arbor
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2Ann Arbor
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 3Detroit
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis—Detroit
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1Detroit
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 2Farmington
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 3Farmington
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 3Farmington Hills
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 YearsPhase 2Farmington Hills
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 3Farmington Hills
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 3Farmington Hills
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/2Grand Rapids
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchPhase 3Livonia
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisPhase 3Rochester Hills

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.